Short interest in Franklin Genomic Advancements ETF (BATS:HELX) increased during the last reporting period, rising from 423.00 to 613.00. This put -% of the company's publicly available shares short.

Short interest in Franklin Genomic Advancements ETF Corp (BATS:HELX) decreased during the last reporting period, falling from 280.30M to 275.20M. This put 1.17% of the company's publicly available shares short.

Based on the recent average volume of 2.48K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.